Curanex Pharmaceuticals Common Stock

CURX | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.29

+$0.35 (+7.09%)

At close: Oct 30, 2026, 3:59 PM ET

$5.10

-$0.19 (-3.63%)

Pre-market: Nov 2, 2026, 4:00 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+7.09%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

+1.0 pts

Fundamentals Weak

Market Sentiment Neutral

Moat None

Sector Rank #979/1028 (Top 95%)

Full Analysis

Key Statistics

Market Data

Market Cap $8.3M

1D Range

4.88 5.55

52W Range

3.66 13.55

Valuation (TTM)

PE -0.72

PB 1.73

EV/EBITDA -0.54

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target $0.00

Cash Flow

FCF Yield -145.6%

SBC Adj. FCF Yield -145.7%

SBC Impact -0.1%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -136.7% | N/A

FCF 3Y | 5Y N/A | N/A

Returns

ROA -206.3%

ROE -109.1%

ROIC -208.4%

Financial Health

Net Cash

$2.66M

Current Ratio 45.95

Interest Coverage -2,580.17

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their ...

Sector Healthcare

Industry Biotechnology

Employees 6

IPO Date Aug 26, 2025

Website www.curanexpharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.